注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
European Biotech Acquisition Corp是一家荷蘭的空白支票公司。該公司成立的目的是進行合併、股份交換、資產收購、股份購買、重組或一個或多個業務或公司與類似業務合併。該公司打算主要在歐洲生命科學領域尋求目標公司。它專注於在包括腫瘤學、糖尿病、心髒病學、中樞神經系統(CNS)和罕見疾病在內的各種治療領域臨床開發中對候選治療藥物進行投資。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Quan Dong Nguyen | - | 2022 | Member of Scientific Advisory Board |
Peter K. Kaiser | - | 2022 | Member of Scientific Advisory Board |
Kuldev Singh | - | - | Member of Scientific Advisory Board |
Anat Loewenstein | - | 2022 | Member of Scientific Advisory Board |
Pablo Villoslada | - | 2022 | Member of Scientific Advisory Board |
Anthony A. Rosenberg | 71 | 2018 | Independent Chairman |
Riad Sherif | 56 | 2017 | CEO & Director |
Martijn Kleijwegt | 69 | 2023 | Independent Director |
Lionel Carnot | 57 | 2017 | Independent Director |
Christophe Baudouin | 63 | 2022 | Member of Scientific Advisory Board |
Arshad M. Khanani | - | 2022 | Chair of Retina Scientific Advisory Board |
Christina M. Ackermann | 59 | 2023 | Independent Director |
Pravin U. Dugel | 60 | 2023 | Independent Director |
Eric D. Donnenfeld | 68 | - | Chair of Cornea Scientific Advisory Board |
David S. Boyer | - | 2024 | Member of Scientific Advisory Board |
Geraldine O'Keeffe | - | 2023 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核